GlobeNewswire by notified

A.P. Møller - Mærsk A/S – Transaktioner i henhold til aktietilbagekøbsprogram

11.9.2023 15:26:15 CEST | GlobeNewswire by notified

Del

SELSKABSMEDDELELSE

A.P. Møller - Mærsk A/S – Transaktioner i henhold til aktietilbagekøbsprogram

Den 5. maj 2021 annoncerede A.P. Møller - Mærsk A/S (“Selskabet”) et aktietilbagekøbsprogram til en værdi af op til DKK 32 mia. (ca. USD 5 mia.), der vil blive opkøbt over en periode på op til to år. Den 12. august 2022 offentliggjorde Selskabet en forøgelse af det nuværende aktietilbagekøbsprogram fra DKK 32 mia. (ca. USD 5 mia.) til DKK 39,3 mia. (ca. USD 6 mia.).  

Som annonceret den 4. maj 2023, vil Selskabet i fjerde fase af programmet, der løber fra 8. maj 2023 til 2. november 2023, købe egne A-aktier og B-aktier for et beløb op til DKK 11 mia. Fjerde fase af tilbagekøbsprogrammet gennemføres i overensstemmelse med EU Kommissionens forordning nr. 596/2014 af 16. april 2014 (MAR) og EU Kommissionens delegerede forordning 2016/1052 (”Safe Harbour Regulativet”).                                                                                                       
Under aktietilbagekøbsprogrammet er der i perioden fra 4. september mandag til 8. september fredag foretaget følgende transaktioner:

Antal
A aktier		Gennemsnitlig
købspris A aktier, DKK		Transaktionsværdi,
A aktier, DKK
I alt, seneste meddelelse (marked og A.P. Møller Holding A/S)449.2136.893.679.751
 4 september 202356012.732.50007.130.200
 5 september 202353012.478.52836.613.620
 6 september 202353012.442.47176.594.510
 7 september 202353012.154.67926.441.980
 8 september 202355012.158.78186.687.330
Total 4. - 8. september 20232.70033.467.640
Køb fra A. P. Møller Holding A/S*2.86312.395.461635.488.207
Total i fjerde fase af aktie-tilbagekøbsprogrammet (marked og A.P. Møller Holding A/S)115.1581.435.870.359
Total under aktietilbagekøbs-
programmet (marked og A.P. Møller Holding A/S)		454.7766.962.635.598
Antal
B aktier		Gennemsnitlig
købspris B aktier, DKK		Transaktionsværdi,
B aktier, DKK
I alt, seneste meddelelse (marked, A.P. Møller Holding A/S og Familiefonden)1.873.79229.998.435.616
 4 september 20232.23512.903.966428.840.365
 5 september 20232.11512.684.768326.828.285
 6 september 20232.11512.657.257726.770.100
 7 september 20232.11512.385.671426.195.695
 8 september 20232.19412.353.062927.102.620
Total 4. - 8. september 202310.774135.737.065
Køb fra A. P. Møller Holding A/S*8.63612.598.5865108.801.393
Købt fra Familiefonden*2.72112.598.650634.280.928
Total i fjerde fase af aktie-tilbagekøbsprogrammet (marked, A.P. Møller Holding A/S og Familiefonden)458.2305.805.313.003
Total under aktietilbagekøbs-
programmet (marked, A.P. Møller Holding A/S og Familiefonden)		1.895.92330.277.255.002


*) I henhold til separate aftaler deltager A.P. Møller Holding A/S og A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond (Familiefonden) på pro rata basis i forhold til aktier købt under tilbagekøbsprogrammet.

Side 1 af 2

Efter ovenstående transaktioner ejer Selskabet i alt 195.554 A-aktier og 829.691 B-aktier som egne aktier, svarende til 5,84% af aktiekapitalen.

Detaljerede handelsoplysninger er vedhæftet som bilag.

København, 11. september 2023

Kontaktpersoner:

Head of Investor Relations, Stefan Gruber, tlf. +45 5357 1650
Head of Media Relations, Jesper Løv, tlf. +45 6114 1521

Side 2 af 2

Vedhæftede filer

For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.
For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.

Information om GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeddelelser fra GlobeNewswire by notified

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra GlobeNewswire by notified

FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing ACTEMRA®29.9.2023 22:06:00 CEST | Press release

TOFIDENCE (BIIB800) becomes the first tocilizumab biosimilar to gain FDA approval in the United States FDA approval is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE to the reference product ACTEMRA CAMBRIDGE, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA. The TOFIDENCE intravenous formulation is approved for the treatment of moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis. TOFIDENCE is the first tocilizumab biosimilar approved in the United States. Biosimilars are biologic products that have been demonstrated to have equivalent efficacy and comparable safety as the approved reference product, with the advantage that they may offer cost savings and promote

Monument Reports Fourth Quarter and Fiscal 2023 Results29.9.2023 21:26:28 CEST | Press release

Gross Revenue of US$12.39 Million and Cash Cost of US$917/Oz for Gold Sulphide Production and US$1,622/Oz for Gold Oxide Production VANCOUVER, British Columbia, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its annual financial results for the year ended June 30, 2023. All amounts are in United States dollars unless otherwise indicated (refer to www.sedar.com for full financial results). Cathy Zhai, the President and CEO commented, “Fiscal 2023 was a milestone year for the Company with the gold sulphide project completed, and the flotation plant was put into production at the Selinsing Gold Mine in Malaysia. The commercial production has also been reached in August 2023 subsequent to the year end. It again demonstrates Monument has been able to deliver what’s been promised and now we are ready for the next corporate move.” Fiscal Year 2023 Highlights: Construction of the Selinsing sulphide flotation pla

Nokia Corporation: Repurchase of own shares on 29.09.202329.9.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 29 September 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 29.09.2023 Espoo, Finland – On 29 September 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL319,5513.57CEUX58,3773.57AQEU11,0113.57TQEX4,7613.57Total393,7003.57 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 Januar

EPH European Property Holdings PLC announces Unaudited Interim Results for the Six Months to 30 June 2023 and appointment of Management Committee Members29.9.2023 19:00:00 CEST | Press release

29 September 2023, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR BUSINESS HIGHLIGHTS FIRST HALF YEAR OF 2023 With an established portfolio of high-quality properties in prime locations in Europe occupied by tenants with strong credit ratings, combined with professional asset management, EPH European Property Holdings PLC (“EPH” or the “Company”) has demon-strated operational stability in the first six months of 2023, despite the ongoing market environment challenges. As a result, EPH not only achieved almost full occupancy throughout its European portfolio, it also increased rental income.The sale of the Company’s Russian portfolio was concluded in April 2023, following the Extraordinary General Meeting (held on 1 November 2022) at which the shareholders of EPH authorised the Board of Directors to sell EPH Group’s entire Russian property portfolio by way of a management buyout. Upon disposal of the Russian segment in the first half of 2023, the Company reclassified the

Oxurion Publishes First Half 2023 Results29.9.2023 19:00:00 CEST | Press release

Regulated Information Leuven, BELGIUM, Boston, MA, US –September 29, 2023 – 7.00PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today published its financial and business update for the six-month period ending June 30, 2023. The half-year report is available in the “Investors” section of the Company’s website and can also be downloaded as a PDF. About Oxurion Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel